2.0
5 Mar 2021
Former employee, more than 5 years
Oklahoma City, OK
Recommend
CEO approval
Business outlook
Pros
Great clinical products and new product introduction
Cons
Management is very weak and there is extremely limited upward mobility. They target EPs when they should target CV surgeons